oxycodone has been researched along with Uterine Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Affonso, BB; Cavalcante, RN; Freire, GM; Galastri, FL; Messina, M; Motta-Leal-Filho, JM; Nasser, F; Rocha, RD | 1 |
1 trial(s) available for oxycodone and Uterine Neoplasms
| Article | Year |
|---|---|
Controlled-release oxycodone improves pain management after uterine artery embolisation for symptomatic fibroids.
Topics: Adult; Analgesics, Opioid; Female; Humans; Leiomyoma; Length of Stay; Morphine; Oxycodone; Pain, Postoperative; Prospective Studies; Treatment Outcome; Uterine Artery Embolization; Uterine Neoplasms | 2017 |